NeuroPace (NPCE) Net Equity Issued and Repurchased (2024 - 2025)
NeuroPace (NPCE) posted Net Equity Issued and Repurchased of -$50000.0 for Q3 2025, up 91.09% on a QoQ basis from -$561000.0 in Q2 2025, and down 101.67% year-over-year from $3.0 million in Q3 2024.
Powered by 
Analysis
NeuroPace (NPCE) Net Equity Issued and Repurchased (2024 - 2025) Analysis & Trends
NeuroPace has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at -$50000.0 in Q3 2025.
- On a quarterly basis, Net Equity Issued and Repurchased fell 101.67% year-over-year to -$50000.0 in Q3 2025; TTM through Jun 2026 was -$50000.0, a 100.07% decrease from a year earlier, with the FY2025 full-year figure at $69.7 million, up 1948.65% from the prior year.
- Net Equity Issued and Repurchased was -$50000.0 for Q3 2025 at NeuroPace, up from -$561000.0 in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $70.3 million in Q1 2025, with the low at -$561000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | NeuroPace | 493.15 Mn | 441.45 Mn | 18.91 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -50,000.00 |
| Jun 30, 2025 | -561,000.00 |
| Mar 31, 2025 | 70.27 Mn |
| Dec 31, 2024 | 468,000.00 |
| Sep 30, 2024 | 3.00 Mn |